NPPA issued a notification regarding the fixation of the retail price of Rosuvastatin Calcium IP Eq. to Rosuvastatin 10 mg (As film coated tablet) + Aspirin IP 75 mg (As Gastro - resistant Tablet) + Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg (as film coated tablet)' for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Sun Pharmaceutical Industries Ltd. (Marketer)

Sep 03, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on September 01, 2026 issued a notification regarding the fixation of the retail price of Rosuvastatin Calcium IP Eq. to Rosuvastatin 10 mg (as film-coated tablet) + Aspirin IP 75 mg (as gastro-resistant tablet) + Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg (as film-coated tablet).

It states that the price for each hard gelatin capsule containing Rosuvastatin Calcium IP Eq. to Rosuvastatin 10 mg (as film-coated tablet) + Aspirin IP 75 mg (as gastro-resistant tablet) + Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg (as film-coated tablet) has been fixed at Rs. 16.56/- excluding GST.

[Notification No. - 19(5302)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT